Stay updated with breaking news from Param Desai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla stock slipped 3.98% to Rs 897.7 against the previous close of Rs 934.90 on BSE. The large cap share has lost 1.38 % in one year and fallen 13.34% since the beginning of this year.
Eris Lifesciences has been on an acquisition spree in a bid to diversify its offerings. The company recently bought nine dermatology brands from both Dr Reddy’s Laboratories and Glenmark Pharma.
A sharp focus on biosimilars has propelled low-profile Aurobindo Pharma to second place in the Indian pharma pecking order, where it has stayed despite the pandemic. The journey to No. 1, though, will be tougher - Issue Date: Sep 18, 2022
Fringe benefit? Ortho clinic stock rides Covid wave, surges 50% in a month SECTIONS Share Synopsis The company is currently valued at Rs 1,700 crore, much of which has come during the last one year, as the stock gained 155 per cent. In fact, in the last one month alone, the stock has climbed 50 per cent. Shutterstock.com Analysts believe the frenzy to acquire the company’s shares was largely due to expected earnings from home care and Covid-19 treatment as well as the ongoing vaccination drive. Related NSE Explore Now NEW DELHI: This smallcap company operates a small chain of hospitals, mos...